BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11984811)

  • 1. Letter to the editor: acute myeloid leukemia in a patient surviving retinoblastoma.
    Gallegos-Castorena S; Medina-Sansón A; González-Montalvo P; Martínez-Avalos A; Zafra de la Rosa GZ
    Med Pediatr Oncol; 2002 Jun; 38(6):450. PubMed ID: 11984811
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.
    Weintraub M; Revel-Vilk S; Charit M; Aker M; Pe'er J
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):646-8. PubMed ID: 17805043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
    Gombos DS; Hungerford J; Abramson DH; Kingston J; Chantada G; Dunkel IJ; Antoneli CB; Greenwald M; Haik BG; Leal CA; Medina-Sanson A; Schefler AC; Veerakul G; Wieland R; Bornfeld N; Wilson MW; Yu CB
    Ophthalmology; 2007 Jul; 114(7):1378-83. PubMed ID: 17613328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
    Nishimura S; Sato T; Ueda H; Ueda K
    J Clin Oncol; 2001 Nov; 19(21):4182-3. PubMed ID: 11689590
    [No Abstract]   [Full Text] [Related]  

  • 5. More about second cancers after retinoblastoma.
    Meadows AT; Leahey AM
    J Natl Cancer Inst; 2008 Dec; 100(24):1743-5. PubMed ID: 19066272
    [No Abstract]   [Full Text] [Related]  

  • 6. A second leiomyosarcoma in the urinary bladder of a child with a history of retinoblastoma 12 years following partial cystectomy.
    Brucker B; Ernst L; Meadows A; Zderic S
    Pediatr Blood Cancer; 2006 Jun; 46(7):811-4. PubMed ID: 16470582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New retinoblastoma tumor formation in children initially treated with systemic carboplatin.
    Lee TC; Hayashi NI; Dunkel IJ; Beaverson K; Novetsky D; Abramson DH
    Ophthalmology; 2003 Oct; 110(10):1989-94; discussion 1994-5. PubMed ID: 14522776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview: chemotherapy for retinoblastoma: an expanding area of clinical research.
    Schouten-Van Meeteren AY; Moll AC; Imhof SM; Veerman AJ
    Med Pediatr Oncol; 2002 Jun; 38(6):428-38. PubMed ID: 11984806
    [No Abstract]   [Full Text] [Related]  

  • 9. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
    Larson RA
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
    [No Abstract]   [Full Text] [Related]  

  • 10. Incidence of new tumor formation in patients with hereditary retinoblastoma treated with primary systemic chemotherapy: is there a preventive effect?
    Wilson MW; Haik BG; Billups CA; Rodriguez-Galindo C
    Ophthalmology; 2007 Nov; 114(11):2077-82. PubMed ID: 17628684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adverse events of chemotherapy for retinoblastoma: what are they? Do we know?
    Rizzuti AE; Dunkel IJ; Abramson DH
    Arch Ophthalmol; 2008 Jun; 126(6):862-5. PubMed ID: 18541855
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periocular chemotherapy for retinoblastoma: success with problems?
    Abramson DH
    Arch Ophthalmol; 2005 Jan; 123(1):128-9; author reply 129. PubMed ID: 15642840
    [No Abstract]   [Full Text] [Related]  

  • 14. A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy.
    Lambert MP; Shields C; Meadows AT
    Pediatr Blood Cancer; 2008 Feb; 50(2):223-6. PubMed ID: 17278120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoblastoma: direct chemotherapeutic drug delivery into the vitreous cavity.
    Seregard S; Singh AD
    Br J Ophthalmol; 2012 Apr; 96(4):473-4. PubMed ID: 22421997
    [No Abstract]   [Full Text] [Related]  

  • 16. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Giardiasis in a patient undergoing chemotherapy for retinoblastoma and acute myelogenous leukemia.
    Otsubo K; Sakaki-Nakatsubo H; Taneichi H; Nomura K; Miyawaki T; Tokoro M; Kanegane H
    Pediatr Int; 2013 Aug; 55(4):524-7. PubMed ID: 23910805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual variant of diffuse retinoblastoma in an adult.
    Khanfir K; Chompret A; Frau E; Bloch-Michel E; Tursz T; Le Cesne A
    Acta Oncol; 2008; 47(5):973-4. PubMed ID: 17943473
    [No Abstract]   [Full Text] [Related]  

  • 19. Second Primary Rhabdomyosarcoma in Nonhereditary Unilateral Retinoblastoma Not Treated with Radiotherapy.
    Moon J; Choung HK; Yoo YJ; Kim N; Khwarg SI
    Korean J Ophthalmol; 2017 Aug; 31(4):370-371. PubMed ID: 28682022
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitreoretinal complications of retinoblastoma treatment.
    Tawansy KA; Samuel MA; Shammas M; Murphree AL
    Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.